Testicular cancer - new approaches in surgery and systemic treatment
Poster Session 82
-
Location:Room Paris, North Hall (Level 1)
-
Chairs:
-
Aims and objectives of this session This session will update the audience with new indications and outcome results from surgical approaches together with new systemic treatment options for patients with advanced germ cell cancer. In addition, quality of care issues will be discussed based on large registries.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1University of Birmingham, Medical School, Birmingham, United Kingdom, 2St George’s University Hospitals NHS Foundation Trust, Dept. of Urological Oncology, London, United Kingdom, 3University of Warwick, Cancer Research Unit, Coventry, United Kingdom, 4University Hospitals Birmingham NHS Foundation Trust, Dept. of Oncology, Birmingham, United Kingdom, 5University Hospitals Birmingham NHS Foundation Trust, Dept. of Informatics, Birmingham, United Kingdom, 6University of Leeds, Leeds Institute of Cancer & Pathology, Leeds, United Kingdom, 7University of Birmingham, School of Cancer Sciences, Birmingham, United Kingdom
Institutes: 1University of Medicine and Pharmacy, Targu Mures, Romania and European Institute of Oncology, Dept. of Cell and Molecular Biology and Dept. of Urology, Milan, Italy, 2European Institute of Oncology, Dept. of Urology, Milan, Italy, 3European Institute of Oncology, Dept. of Pathology, Milan, Italy, 4European Institute of Oncology and University of Milan, Dept. of Urology, Milan, Italy
Institutes: 1University Hospital Zurich, University of Zurich, Dept. of Urology, Zurich, Switzerland, 2University Hospital Zurich, University of Zurich, Dept. of Oncology, Zurich, Switzerland, 3University Hospital Zurich, University of Zurich, Dept. of Pathology and Molecular Pathology, Zurich, Switzerland
Institutes: 1European Institute of Oncology, Dept. of Urology, Milan, Italy, 2European Institute of Oncology, Dept. of Radiotherapy, Milan, Italy, 3European Institute of Oncology, Dept. of Oncology, Milan, Italy
Institutes: 1Fondazione Irccs Istituto Nazionale Tumori, Dept. of Urology, Milan, Italy, 2Mox- Politecnico Di Milano, Dept. of Mathematics, Milan, Italy, 3Fondazione Irccs Istituto Nazionale Tumori, Dept. of Medical Oncology, Milan, Italy, 4Fondazione Irccs Istituto Nazionale Tumori, Dept. of Pathology, Milan, Italy, 5Fondazione Irccs Istituto Nazionale Tumori, Emeritus, Milan, Italy
Institutes: 1Chu Toulouse Rangueil, Dept. of Vascular Surgery, Toulouse, France, 2Chu Toulouse Rangueil, Dept. of Radiology, Toulouse, France, 3Institut Universitaire Du Cancer, Dept. of Pathology, Toulouse, France, 4Institut Universitaire Du Cancer, Dept. of Urology, Toulouse, France, 5Institut Universitaire Du Cancer, Dept. of Medical Oncology, Toulouse, France
Institutes: 1, IRCCS Ospedale San Raffaele, Dept. of Urology, Milan, Italy, 2University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Dept. of Orthopedic Surgery, Düsseldorf, Germany, 3University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Dept. of Urology, Düsseldorf, Germany
Institutes: 1University Medical Center Hamburg-Eppendorf, Dept. of Urology, Hamburg, Germany, 2Albertinen Hospital, Dept. of Urology, Hamburg, Germany, 3Bundeswehr Medical Center Hamburg, Dept. of Urology, Hamburg, Germany, 4University Medical Center Hamburg-Eppendorf, Dept. of Ophthalmology, Hamburg, Germany, 5University Medical Center Hamburg-Eppendorf, Dept. of Medical Oncology, Hamburg, Germany
Institutes: 1Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2Fondazione IRCCS Policlinico San Matteo, Dept. of Medical Oncology, Pavia, Italy, 3EBMT, EBMT Study Offices, Paris, France, 4Fondazione IRCCS Istituto Nazionale Dei Tumori, Dept. of Medical Oncology, Milan, Italy, 5Hospital of Ravenna, Dept. of Hematology, Ravenna, Italy
Institutes: 1Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Medical Oncology, Milan, Italy, 2Fondazione IRCCS – Istituto Nazionale Dei Tumori, Clinical Epidemiology and Trials Organization Unit, Milan, Italy, 3Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Radiology, Milan, Italy, 4Fondazione IRCCS – Istituto Nazionale Dei Tumori, Pharmacy Unit, Milan, Italy, 5Fondazione IRCCS – Istituto Nazionale Dei Tumori, Nuclear Medicine – PET Unit, Milan, Italy, 6Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Experimental Oncology and Molecular Medicine, Milan, Italy, 7Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Pathology, Milan, Italy, 8Fondazione IRCCS – Istituto Nazionale Dei Tumori, Dept. of Urology, Milan, Italy